drugset
drugset / Trial / NCT07007533

A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

NCT07007533 ↗

Phase 1 Completed 38 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelScreening

Summary

This study will compare and evaluate the safety, tolerability and pharmacokinetics between DA-5223 and DA-5223-R in healthy adult subjects

Timeline

Start
2025-07-04
Primary completion
2025-07-17
Completion
2025-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-5223 Unknown — —
Subject DA-5223-R Unknown — —

Indications

No indication recorded.